0001796271-20-000005.txt : 20200811 0001796271-20-000005.hdr.sgml : 20200811 20200811172800 ACCESSION NUMBER: 0001796271-20-000005 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200807 FILED AS OF DATE: 20200811 DATE AS OF CHANGE: 20200811 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ABRAHAM TODD KEVIN CENTRAL INDEX KEY: 0001796271 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38403 FILM NUMBER: 201093499 MAIL ADDRESS: STREET 1: 111 PETER STREET, SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2G9 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cronos Group Inc. CENTRAL INDEX KEY: 0001656472 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 111 PETER STREET STREET 2: SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2G9 BUSINESS PHONE: (416) 504-0004 MAIL ADDRESS: STREET 1: 111 PETER STREET STREET 2: SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2G9 FORMER COMPANY: FORMER CONFORMED NAME: PharmaCan Capital Corp. DATE OF NAME CHANGE: 20151021 4 1 wf-form4_159718126727726.xml FORM 4 X0306 4 2020-08-07 0 0001656472 Cronos Group Inc. CRON 0001796271 ABRAHAM TODD KEVIN 111 PETER STREET, SUITE 300 TORONTO A6 M5V 2G9 ONTARIO, CANADA 0 1 0 0 Chief Innovation Officer COMMON SHARES 2020-08-07 4 P 0 15000 5.7837 A 15000 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.78 to $5.79, inclusive. The reporting person undertakes to provide to Cronos Group Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Exhibit List: Exhibit 24 - Power of Attorney /s/ Eileen Uy, as attorney-in-fact for Todd K. Abraham 2020-08-11 EX-24 2 a200810abrahamsection16poa.htm ABRAHAMSEC16POA

Todd Kevin Abraham  Exhibit 24


Authorization and Designation
to Sign and File
Section 16 Reporting Forms



    The undersigned, an executive officer of Cronos Group Inc., a corporation
incorporated under the Business Corporations Act (British Columbia) (the "Company"),
does hereby authorize and designate Jerry Barbato, Xiu Ming Shum or Eileen Uy, each
with right to substitute and resubstitute, but for only so long as each of them is an officer
of the Company, to sign and file on his or her behalf the application for the required
Securities and Exchange Commission ("SEC") electronic CIK/CCC codes and any and
all Forms 3, 4 and 5 and Forms 144 relating to equity securities of the Company with the
SEC pursuant to the requirements of Section 16 of the Securities Exchange Act of 1934
("Section 16") and Rule 144 under the Securities Act of 1933, as amended.  This
authorization, unless earlier revoked in writing, shall be valid until the undersigned's
reporting obligations under Section 16 and Rule 144 with respect to equity securities of
the Company shall cease.  All prior such authorizations are hereby revoked.

    IN WITNESS WHEREOF, the undersigned has executed this Authorization and
Designation this 10th day of August, 2020.




                            /s/ Todd Kevin Abraham
                            TODD KEVIN ABRAHAM